TTrialPathMatch Me to Trials
← Back to trials
RecruitingAnxiety Disorders

Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.

Eligible age

8–17 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.

Sponsor: University of Cincinnati

You may qualify if…

  • Written, informed assent and consent.
  • Patients, parent/guardian/LAR must be fluent in the English.
  • 8-17 years of age, inclusive, at Visit 1, and who have a parent/guardian/LAR.
  • Patients must meet DSM-5 criteria for generalized, social and/or separation anxiety disorder, confirmed by the MINI-KID with no lifetime history of mania, OCD or significant history of trauma exposure.
  • PARS score ≥15 at Visits 1 and 2.
  • Caregiver who is willing to consent to be responsible for safety monitoring of the patient, provide information about the patient's condition, oversee the administration of the investigational product.
  • No clinically significant abnormalities on physical examination.
  • Negative pregnancy test at Visit 1 in females.

You may not qualify if…

  • Subjects Co-occurring DSM-5 diagnosis mood (except persistent depressive disorder, unspecified depressive disorder or co- occurring anxiety disorders, provided that the primary diagnosis is generalized, social and/or separation anxiety disorder(s)), eating, bipolar, or psychotic disorders.
  • A history of treatment with SSRIs within 12 weeks of Visit 2 (Baseline) or current pharmacotherapy with CNS effects that require \>5 half-lives for discontinuation.
  • A history of major neurological or medical illness or head trauma with loss of consciousness for ≥5 minutes.
  • Lifetime history of mania, OCD, or significant history of trauma exposure.
  • History of hypersensitivity to sertraline.
  • Lifetime diagnosis of intellectual disability or history of IQ \<70.
  • History of alcohol/substance use disorder or any substance abuse within the past 6 months (nicotine dependence is permitted).
  • Current psychotherapy stable for \<2 months prior to Visit 2 (Baseline).

Where it's recruiting

Ohio

Cincinnati

Source: ClinicalTrials.gov · NCT04221997 · last updated 2024-11-01

Trial With the Treatment of Sertraline in Youth With Generalized, Sepa · TrialPath